Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Internet and Telephone Treatment for smoking cessation: mediators and moderators of short-term abstinence.

Graham AL, Papandonatos GD, Cobb CO, Cobb NK, Niaura RS, Abrams DB, Tinkelman DG.

Nicotine Tob Res. 2015 Mar;17(3):299-308. doi: 10.1093/ntr/ntu144. Epub 2014 Aug 25.

PMID:
25156528
2.

The emergency department action in smoking cessation (EDASC) trial: impact on cessation outcomes.

Katz DA, Holman JE, Nugent AS, Baker LJ, Johnson SR, Hillis SL, Tinkelman DG, Titler MG, Vander Weg MW.

Nicotine Tob Res. 2013 Jun;15(6):1032-43. doi: 10.1093/ntr/nts219. Epub 2012 Nov 2.

PMID:
23125437
3.

Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions.

Morris CD, Waxmonsky JA, May MG, Tinkelman DG, Dickinson M, Giese AA.

Community Ment Health J. 2011 Dec;47(6):694-702. doi: 10.1007/s10597-011-9411-z. Epub 2011 May 10.

PMID:
21556784
4.

A randomized trial of Internet and telephone treatment for smoking cessation.

Graham AL, Cobb NK, Papandonatos GD, Moreno JL, Kang H, Tinkelman DG, Bock BC, Niaura RS, Abrams DB.

Arch Intern Med. 2011 Jan 10;171(1):46-53. doi: 10.1001/archinternmed.2010.451. Erratum in: Arch Intern Med. 2011 Mar 14;171(5):395.

5.

Measuring asthma control is the first step to patient management: a literature review.

Halbert RJ, Tinkelman DG, Globe DR, Lin SL.

J Asthma. 2009 Sep;46(7):659-64. doi: 10.1080/02770900902963128. Review.

PMID:
19728201
6.

COPD screening efforts in primary care: what is the yield?

Tinkelman DG, Price D, Nordyke RJ, Halbert RJ.

Prim Care Respir J. 2007 Feb;16(1):41-8.

7.

Scoring system and clinical application of COPD diagnostic questionnaires.

Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ; COPD Questionnaire Study Group.

Chest. 2006 Jun;129(6):1531-9.

PMID:
16778271
8.

Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.

Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ.

J Asthma. 2006 Jan-Feb;43(1):75-80.

PMID:
16448970
9.

Symptom-based questionnaire for identifying COPD in smokers.

Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Ostrem A, van der Molen T, van Schayck CP.

Respiration. 2006;73(3):285-95. Epub 2005 Dec 5.

10.

Symptom-based questionnaire for differentiating COPD and asthma.

Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Ostrem A, van der Molen T, van Schayck CP.

Respiration. 2006;73(3):296-305. Epub 2005 Dec 5.

11.

Chronic obstructive pulmonary disease in patients under age 65: utilization and costs from a managed care sample.

Tinkelman DG, George D, Halbert RJ.

J Occup Environ Med. 2005 Nov;47(11):1125-30.

PMID:
16282873
12.

Operating a sustainable disease management program for chronic obstructive pulmonary disease.

Endicott L, Corsello P, Prinzi M, Tinkelman DG, Schwartz A.

Lippincotts Case Manag. 2003 Nov-Dec;8(6):252-62; quiz 263-4.

PMID:
14646783
13.

Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma.

Tinkelman DG, Bronsky EA, Gross G, Schoenwetter WF, Spector SL.

J Asthma. 2003 May;40(3):225-36.

PMID:
12807165
14.

Relationships between self-reported asthma utilization and patient characteristics.

Tinkelman DG, McClure DL, Lehr TL, Schwartz AL.

J Asthma. 2002 Dec;39(8):729-36.

PMID:
12507193
15.

Barriers to measuring and achieving optimal outcomes in pediatric asthma.

Naspitz CK, Tinkelman DG.

J Allergy Clin Immunol. 2001 May;107(5 Suppl):S482-4. Review.

PMID:
11344378
16.

Disease management program improves asthma outcomes.

Jowers JR, Schwartz AL, Tinkelman DG, Reed KE, Corsello PR, Mazzei AA, Bender DR, Lochhead RA.

Am J Manag Care. 2000 May;6(5):585-92.

17.

A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma.

Bernstein DI, Cohen R, Ginchansky E, Pedinoff AJ, Tinkelman DG, Winder JA.

J Allergy Clin Immunol. 1998 Apr;101(4 Pt 1):433-8.

PMID:
9564793
18.

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.

Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman DG, Vandewalker ML, Konig P.

J Pediatr. 1998 Mar;132(3 Pt 1):472-7.

PMID:
9544904
19.

The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis.

Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Wood CC.

Allergy Asthma Proc. 1998 Jan-Feb;19(1):23-9.

PMID:
9532321
20.

Proventil HFA and ventolin have similar safety profiles during regular use.

Tinkelman DG, Bleecker ER, Ramsdell J, Ekholm BP, Klinger NM, Colice GL, Slade HB.

Chest. 1998 Feb;113(2):290-6.

PMID:
9498941
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk